Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06570603 · ClinicalTrials.gov registry record · NA

Targeting Components of Distress Tolerance

A NA study of Distress, Emotional, sponsored by University of Arkansas, Fayetteville.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT06570603: Recruiting NA study of Distress, Emotional, sponsored by University of Arkansas, Fayetteville.

NCT06570603 is a NA study of Distress, Emotional that is actively recruiting participants, run by University of Arkansas, Fayetteville. The registered enrollment target is 240 participants, below the 456-participant average among 14 other Distress, Emotional trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06570603, a NA study of Distress, Emotional, is actively recruiting participants, sponsored by University of Arkansas, Fayetteville.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn which aspects of distress intolerance (i.e., difficulties withstanding upsetting emotional states) are the most important for improving effective emotion regulation and associated mental health symptoms. The main questions it aims to answer are: How are willingness to feel upset and self-efficacy for withstanding distress associated with different emotion regulation strategies used in daily life? Does targeting willingness to feel upset and/or self-efficacy for withstanding distress help people use more effective emotion regulation strategies in daily life when they feel upset? Are improvements in emotion regulation strategies in daily life associated with fewer symptoms of mental health problems over time? Participants will: Answer questions about their moods, willingness to feel upset, self-efficacy for withstanding distress and emotion regulation strategies for three weeks using a cell phone app Undergo a willingness, self-efficacy, combined or psychoeducational control intervention in the lab Be prompted to use the intervention skill via the cell phone app during the second week, after the intervention Complete weekly reports of mental health symptoms

Primary Outcome

Emotion regulation strategies reflective of engagement; these are new items developed for this study and are not from an established scale. All items will be rated from 0 (not at all) to 6 (extremely). There will be 7 items assessing labeling ("I'm using emotion words to describe how I feel right now"), processing ("I'm reflecting on or writing about my feelings"), sharing ("I'm sharing how I feel with another person"), physical feeling ("I'm intentionally feeling my feelings in my body"), curio

Conditions Studied

Interventions

  • BEHAVIORAL Psychoeducation
  • BEHAVIORAL Self-Efficacy
  • BEHAVIORAL Willingness

Study Locations (1)

Arkansas

  • University of Arkansas - Fayetteville - Fayetteville

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2024-10-03
Est. Completion 2027-04
Phase NA

What NCT06570603 shows while recruiting

NCT06570603 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 456-participant average among 14 other Distress, Emotional trials with a reported enrollment target (47% lower).

The record links to 1 condition, with Distress, Emotional appearing as the primary indexed condition, and to 3 interventions - of which Psychoeducation is the first listed.

NCT06570603 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT06570603 about?

NCT06570603 is a clinical study titled "Targeting Components of Distress Tolerance". The goal of this clinical trial is to learn which aspects of distress intolerance (i.e., difficulties withstanding upsetting emotional states) are the most important for improving effective emotion regulation and associated mental health symptoms. The main questions it aims to answer are: How are ...

What is the current status of trial NCT06570603?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2024-10-03. Estimated completion is 2027-04.

What conditions does trial NCT06570603 study?

This clinical trial studies the following conditions: Distress, Emotional.

What interventions are being tested in trial NCT06570603?

The interventions under investigation include: Psychoeducation (BEHAVIORAL), Self-Efficacy (BEHAVIORAL), Willingness (BEHAVIORAL).

Who is sponsoring clinical trial NCT06570603?

This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06570603 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Distress, Emotional

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06570603's enrollment target sits among peer trials

240 4th of 14 higher than 11 of 14 other Distress, Emotional trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Distress, Emotional trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06570603, the US trial registry maintained by the National Library of Medicine. NCT06570603 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.